This Study Will Evaluate the Effect and Safety of 626 in Patients With CLE

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study aims to evaluate the efficacy and safety of subcutaneous (SC) 626 versus placebo in adult participants with cutaneous lupus erythematosus (CLE).
Epistemonikos ID: 5d63d6632f649bceace8546acdcec47d5ee18e5d
First added on: Oct 29, 2026